Knee Osteoarthritis Treatment Market 2028 By Treatment Type, End-user and Geography | The Insight Partners

report image

Knee Osteoarthritis Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Treatment Type (Non-Surgical Treatment, Surgical Treatment); End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) and Geography

Report Code: TIPRE00023789 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


- steoarthritis is a degenerative disease that occurs in the joint lining, cartilage, underlying bone, and ligaments. Knee osteoarthritis is the inflammation of the knee joints and is also known as degenerative arthritis of the knee. It is a wear and tear type of arthritis that generally affects individuals above 50 years; however, it can also affect younger individuals. It causes knee cartilage in the knee joint to wear away gradually. The protecting area between the bones shrinks as the cartilage wears away and causes the knee joint to becomes frayed and rough, resulting in friction between the bones. Its symptoms include knee stiffness, warmth in the joint, swelling, and decreased mobility.


The "Global Knee Osteoarthritis Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the knee osteoarthritis treatment market with detailed market segmentation by treatment type, end user, and geography. The report provides key statistics on the market status of the leading knee osteoarthritis treatment market players and offers key trends and opportunities in the market.


    - Based on treatment type, the global knee osteoarthritis treatment market is segmented into non-surgical treatment and surgical treatment.
    - On the basis of end-users, the market is bifurcated into hospitals, ambulatory surgical centers and specialty clinics.


    - The increasing prevalence of knee osteoarthritis and other illnesses such as rheumatoid arthritis and metabolic disorders drive the growth of the knee osteoarthritis treatment market.
    - Increasing cases of obesity, growing lifestyle changes, and growing geriatric population boost market growth.
    - The growing minimally invasive surgical treatments and rapid advancement of technology in the healthcare sector fuel market growth.
    - New product launch to provide improved treatment options to people suffering from knee osteoarthritis propel market growth.


    - Side effects of available therapeutics.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The knee osteoarthritis treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the knee osteoarthritis treatment market in these regions.


COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 pandemic has impacted the knee osteoarthritis treatment market growth. The osteoarthritis?related disorders are expected to cause life?threatening risks for osteoarthritis patients during Covid viral infection. This has led orthopedists and clinicians to take extra care while examining and evaluating osteoarthritis patients from the perspective of osteoarthritis symptoms management and comorbidities that occur because of osteoarthritis treatment during the COVID?19 pandemic. Furthermore, the elective surgeries were canceled, which caused a decrease in patient pool, and only emergency surgeries were allowed, that caused a short-term impact on the market growth. Thus, given the above-mentioned factors, market growth is impacted during the present pandemic era.

Get more information on this report :


The report covers key developments in the knee osteoarthritis treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from knee osteoarthritis treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for knee osteoarthritis treatment in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the knee osteoarthritis treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

    - AVM Biotechnology
    - Bioventus
    - Flexion Therapeutics
    - Anika Therapeutics, Inc
    - OrthoTrophix, Inc.
    - Pfizer Inc.
    - Zimmer Biomet
    - Novartis AG
    - GlaxoSmithKline plc
    - Sanofi SA
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

1. AVM Biotechnology
2. Bioventus
3. Flexion Therapeutics
4. Anika Therapeutics, Inc
5. OrthoTrophix, Inc.
6. Pfizer Inc.
7. Zimmer Biomet
8. Novartis AG
9. GlaxoSmithKline plc
10. Sanofi SA
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount